[go: up one dir, main page]

FR2943670B1 - Derives anticancereux,leur preparation et leur application en therapeutique - Google Patents

Derives anticancereux,leur preparation et leur application en therapeutique

Info

Publication number
FR2943670B1
FR2943670B1 FR0901366A FR0901366A FR2943670B1 FR 2943670 B1 FR2943670 B1 FR 2943670B1 FR 0901366 A FR0901366 A FR 0901366A FR 0901366 A FR0901366 A FR 0901366A FR 2943670 B1 FR2943670 B1 FR 2943670B1
Authority
FR
France
Prior art keywords
preparation
therapeutic application
anticancer derivatives
anticancer
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0901366A
Other languages
English (en)
Other versions
FR2943670A1 (fr
Inventor
Jerome Arigon
Claude Bernhardt
Monsif Bouaboula
Jerome Combet
Sandrine Hilairet
Samir Jegham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0901366A priority Critical patent/FR2943670B1/fr
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Priority to JP2012501350A priority patent/JP2012521397A/ja
Priority to PCT/FR2010/050512 priority patent/WO2010109123A1/fr
Priority to US13/258,847 priority patent/US20120094986A1/en
Priority to EP10715960A priority patent/EP2411367A1/fr
Priority to ARP100100921A priority patent/AR075921A1/es
Priority to TW099108577A priority patent/TW201102368A/zh
Priority to UY0001032516A priority patent/UY32516A/es
Publication of FR2943670A1 publication Critical patent/FR2943670A1/fr
Application granted granted Critical
Publication of FR2943670B1 publication Critical patent/FR2943670B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR0901366A 2009-03-24 2009-03-24 Derives anticancereux,leur preparation et leur application en therapeutique Expired - Fee Related FR2943670B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0901366A FR2943670B1 (fr) 2009-03-24 2009-03-24 Derives anticancereux,leur preparation et leur application en therapeutique
PCT/FR2010/050512 WO2010109123A1 (fr) 2009-03-24 2010-03-22 Derives anticancereux, leur preparation et leur application en therapeutique
US13/258,847 US20120094986A1 (en) 2009-03-24 2010-03-22 Anticancer deriviatives, preparation thereof, and therapeutic use thereof
EP10715960A EP2411367A1 (fr) 2009-03-24 2010-03-22 Derives anticancereux, leur preparation et leur application en therapeutique
JP2012501350A JP2012521397A (ja) 2009-03-24 2010-03-22 抗癌誘導体、この調製、およびこの治療的使用
ARP100100921A AR075921A1 (es) 2009-03-24 2010-03-23 Derivados anticancerigenos, su preparacion y su aplicacion en terapeutica
TW099108577A TW201102368A (en) 2009-03-24 2010-03-23 Anticancer derivatives, preparation thereof and therapeutic use thereof
UY0001032516A UY32516A (es) 2009-03-24 2010-03-24 Derivados anticancerígenos de la nicotinamida, su preparación y su aplicación en terapéutica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0901366A FR2943670B1 (fr) 2009-03-24 2009-03-24 Derives anticancereux,leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2943670A1 FR2943670A1 (fr) 2010-10-01
FR2943670B1 true FR2943670B1 (fr) 2011-05-06

Family

ID=40823131

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0901366A Expired - Fee Related FR2943670B1 (fr) 2009-03-24 2009-03-24 Derives anticancereux,leur preparation et leur application en therapeutique

Country Status (8)

Country Link
US (1) US20120094986A1 (fr)
EP (1) EP2411367A1 (fr)
JP (1) JP2012521397A (fr)
AR (1) AR075921A1 (fr)
FR (1) FR2943670B1 (fr)
TW (1) TW201102368A (fr)
UY (1) UY32516A (fr)
WO (1) WO2010109123A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5929683B2 (ja) * 2012-10-09 2016-06-08 信越化学工業株式会社 半導体基板の分離移載方法及び半導体基板用分離移載装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1140840B1 (fr) * 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. Diphenylurees a substituants -g(v)-carboxyaryles, inhibitrices de kinase raf
EP1626714B1 (fr) * 2003-05-20 2007-07-04 Bayer Pharmaceuticals Corporation Urees de diaryle pour des maladies mediees par le recepteur du facteur de croissance derive des plaquettes
FR2921657A1 (fr) * 2007-09-28 2009-04-03 Sanofi Aventis Sa Derives de nicotinamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
AR075921A1 (es) 2011-05-04
EP2411367A1 (fr) 2012-02-01
US20120094986A1 (en) 2012-04-19
UY32516A (es) 2010-10-29
JP2012521397A (ja) 2012-09-13
FR2943670A1 (fr) 2010-10-01
WO2010109123A1 (fr) 2010-09-30
TW201102368A (en) 2011-01-16

Similar Documents

Publication Publication Date Title
FR2949470B1 (fr) Derives anticancereux, leur preparation et leur application therapeutique
FR2963007B1 (fr) Derives anticancereux, leur preparation et leur application therapeutique
FR2953520B1 (fr) Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique
FR2933700B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
FR2945534B1 (fr) DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2952934B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
FR2926556B1 (fr) Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
FR2943669B1 (fr) Derives de nicotinamide,leur preparation et leur application en therapeutique
FR2915199B1 (fr) Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
FR2948939B1 (fr) Derives de 2h pyridazin-3-ones, leur preparation et leur application en therapeutique humaine
FR2917413B1 (fr) Derives de 7-alkynyl-1,8-naphthyridones, leur preparation et leur application en therapeutique
FR2954943B1 (fr) Derives de pyridino-pyridinones arylsulfonamides, leur preparation et leur application en therapeutique
FR2947546B1 (fr) Derives de pyrazoles, leur preparation et leur application en therapeutique
FR2927625B1 (fr) Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
BRPI1014904A2 (pt) derivados de quinazolinadiona, preparação dos mesmos e vários usos terapêuticos dos mesmos.
FR2940284B1 (fr) Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique
FR2930249B1 (fr) Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique.
FR2932481B1 (fr) Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique.
FR2967672B1 (fr) Derives de nitrobenzothiazoles, leur preparation et leurs applications therapeutiques
FR2986232B1 (fr) Derives heterocycliques bicycliques, leur preparation et leur application en therapeutique
FR2930939B1 (fr) Derives de pyrrole, leur preparation et leur application en therapeutique
FR2934594B1 (fr) Derives de thiophene-2-carboxamide, leur preparation et leur application en therapeutique.
FR2911605B1 (fr) Derives de pyrrolopyridine-2-carbowamides, leur preparation et leur application en therapeutique
FR2919610B1 (fr) Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique
FR2941946B1 (fr) Derives de 3-benzofuranyl-indol-2-one-3-acetamidopiperazines substitues, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20131129